Introduction to Zoetis Inc.

Zoetis Inc. stands as the preeminent global leader in animal health, a cornerstone of the broader healthcare industry that bridges veterinary medicine, biotechnology, and pharmaceutical innovation. Headquartered in Parsippany, New Jersey, United States, Zoetis Inc. operates in over 45 countries and serves veterinarians, livestock producers, pet owners, and governments across 100+ markets. With annual revenues exceeding $8 billion and a workforce of approximately 13,000 dedicated professionals, the company has earned a formidable reputation for scientific excellence, ethical business practices, and an unwavering commitment to improving the lives of animals and the communities they support. Zoetis Inc. is widely recognized as a top healthcare company, consistently ranking among the Fortune 500 and receiving accolades for its robust R&D pipeline, sustainable supply chain, and customer-centric approach. The company’s portfolio encompasses vaccines, diagnostics, therapeutics, and genetic technologies that address the most pressing health challenges in companion animals, poultry, swine, cattle, aquaculture, and equine species. Organizations ranging from small veterinary practices to large-scale agribusinesses rely on Zoetis Inc. to deliver evidence-based solutions that enhance animal welfare, food safety, and public health. By leveraging cutting-edge science, including genomics, biologics, and digital health platforms, Zoetis Inc. continues to set the standard for what a modern animal health company can achieve.

Company History and Business Evolution

The origins of Zoetis Inc. trace back to 1952, when Pfizer Inc., one of the world’s largest pharmaceutical companies, established an animal health division to develop medications and vaccines for livestock and companion animals. For over six decades, this division operated as a subsidiary of Pfizer, building a rich legacy of innovation through landmark products such as the first recombinant vaccine for canine distemper and the broad-spectrum antibiotic Draxxin. In 2013, Pfizer executed a strategic spinoff, creating an independent publicly traded entity named Zoetis Inc., derived from the Greek word “zoetic” meaning “full of life.” This separation allowed Zoetis Inc. to focus exclusively on animal health, unburdened by the operational and strategic priorities of a human pharmaceutical giant. Since its IPO on the New York Stock Exchange (ticker: ZTS), the company has experienced explosive growth through a combination of organic R&D investments and targeted acquisitions. Notable milestones include the 2015 acquisition of Abbott’s animal health business, which brought a suite of diagnostics and nutritional products; the 2017 purchase of Nexvet, a pioneer in monoclonal antibodies for animals; and the 2020 acquisition of PharmAust’s veterinary cancer assets. In 2022, Zoetis Inc. completed the largest deal in its history, acquiring J&J’s animal health division for $6.2 billion, significantly expanding its presence in pain management dermatology and specialty therapeutics. Under the leadership of CEO Kristin Peck (appointed in 2020), the company has accelerated its digital transformation, launched a comprehensive sustainability strategy, and deepened its commitment to the United Nations Sustainable Development Goals. Today, Zoetis Inc. operates state-of-the-art manufacturing facilities, research centers in the US, Europe, and Asia, and a global distribution network that delivers life-saving products to veterinarians and farmers around the clock.

Zoetis Inc. at a Glance

• Headquarters: Parsippany, New Jersey, USA
• Founded: 1952 (as Pfizer Animal Health); spun off in 2013
• CEO: Kristin Peck (since January 2020)
• Revenue: $8.1 billion (FY 2023)
• Employees: Approximately 13,000 globally
• Stock Symbol: ZTS (NYSE)
• Industry: Animal Health (Healthcare)
• Key Products: Vaccines, anti-infectives, parasiticides, diagnostics, genetic tests, monoclonal antibodies
• Global Presence: Operations in 45+ countries, products sold in 100+ countries
• R&D Investment: Over $600 million annually (7.5% of revenue)
• Manufacturing Sites: 20+ facilities across the US, Europe, Latin America, and Asia
• Key Acquisitions: Abbott Animal Health (2015), Nexvet (2017), J&J Animal Health (2022)
• Major Competitors: Merck Animal Health, Boehringer Ingelheim, Elanco, Virbac
• Awards & Recognition: Fortune’s World’s Most Admired Companies, Forbes’ Best Employers, Dow Jones Sustainability Index
• Core Focus Areas: Companion animal, livestock, poultry, swine, aquaculture, equine
• Digital Health Platforms: VETSPACE, Prognostic; pet owner apps
• Sustainability Goals: Net zero by 2040, reduction of antibiotic use
• Regulatory Approvals: FDA, EMA, CFDA, and over 100 other national agencies
• Leadership Team: Experienced executives from pharma, biotech, and diagnostic sectors
• Trusted By: 500,000+ veterinary clinics, feedlots, and livestock operations worldwide

Mission, Vision, and Core Corporate Values

Zoetis Inc. is driven by a mission to “nourish the world and advance care for animals.” This mission is actualized through a vision to become the world’s most trusted provider of animal health solutions. The company’s core values form the bedrock of its corporate culture and decision-making processes: Integrity – acting ethically and transparently in all stakeholder interactions; Innovation – continuously pushing the boundaries of science to deliver breakthrough therapies; Courage – taking calculated risks to improve animal and human well-being; Collaboration – fostering internal and external partnerships to amplify impact; and Excellence – holding itself to the highest standards of quality, safety, and customer service. These values are embedded in every aspect of operations, from R&D prioritization to employee performance reviews. Zoetis Inc. also subscribes to the “One Health” philosophy, recognizing the inseparable link between animal health, human health, and environmental sustainability. This principle guides the company’s advocacy for responsible antibiotic use, zoonotic disease prevention, and climate-smart agriculture practices.

Business Strategy and Future Roadmap

Zoetis Inc.’s business strategy revolves around three pillars: Innovation Leadership, Commercial Excellence, and Operational Efficiency. Under innovation, the company allocates substantial resources to next-generation modalities such as mRNA vaccines, gene editing, and microbiome therapies. The pipeline includes over 100 projects targeting unmet medical needs in oncology, dermatology, immunology, and pain management. Commercial excellence is achieved through a direct sales force of 4,000+ representatives, strategic key account management, and a robust e-commerce platform (VETSPACE) that facilitates online ordering, telemedicine, and continuing education. Operational efficiency is driven by lean manufacturing, predictive supply chain analytics, and automation. The future roadmap, outlined in the 2025 Strategic Plan, includes expanding into high-growth emerging markets (India, Brazil, China), launching 20+ new products within five years, and achieving carbon neutrality by 2040. Zoetis Inc. also plans to deepen its involvement in precision livestock farming through partnerships with tech startups and data analytics firms.

Products, Technologies, and Services

Zoetis Inc. offers one of the broadest portfolios in animal health. Key product categories include: Vaccines (Core EQ Innovator, Vanguard, Poulvac), Anti-infectives (Draxxin, Excede, Convenia), Parasiticides (Simparica Trio, Revolution), Diagnostics (WITNESS, VetScan, Catalyst One), Genetic Technologies (CLARIFIDE genomic tests for cattle), and Therapeutic Monoclonal Antibodies (Zoetis’ first mAb for canine osteoarthritis pain). The company also provides Pet Owner Solutions such as Allergy immunotherapy and the VetPen insulin injector for diabetic cats and dogs. In the digital health realm, VETSPACE is a comprehensive clinic management platform used by over 30,000 veterinary practices worldwide. Prognostic is an AI-driven tool that predicts disease outbreaks in livestock operations. Zoetis Inc. also operates Zoetis Reference Laboratories offering advanced diagnostic testing services for veterinarians and research institutions.

Industries and Markets Served

Zoetis Inc. serves a diverse array of industries within the healthcare and agriculture sectors. Companion Animal (dogs and cats) accounts for roughly 55% of company revenue, driven by pet humanization trends and increasing willingness to spend on advanced veterinary care. Livestock (cattle, swine, poultry) represents 35% of revenue, with a strong focus on disease prevention and production efficiency. The company also serves Equine (horses) for sport, racing, and pleasure, and Aquaculture (salmon, shrimp) where vaccines are critical for sustainable farming. Additionally, Zoetis Inc. provides Public Health solutions through vaccines that prevent zoonotic diseases (e.g., avian influenza, rabies) and diagnostic tools for food safety testing. The company’s primary customers include veterinary clinics, animal hospitals, livestock producers, integrated poultry companies, governments, and research institutions. Geographically, the US market is the largest (60% of revenue), followed by Europe/Middle East/Africa, Latin America, and Asia Pacific.

Leadership and Management Philosophy

Zoetis Inc. is led by a highly experienced executive team with deep roots in pharmaceutical, biotechnology, and animal health industries. CEO Kristin Peck previously held senior roles at Pfizer and Zoetis, spearheading the company’s strategic pivot toward companion animal focus and digital health. The leadership philosophy emphasizes empowered teams, data-driven decision making, and a customer-first mindset. The company operates with a flat organizational structure that encourages cross-functional collaboration between R&D, commercial, and supply chain units. Zoetis Inc. invests heavily in leadership development programs, including the Zoetis Leadership Institute, which prepares high-potential employees for global roles. Diversity and inclusion are integral, with the company maintaining gender parity in senior management and running employee resource groups for women, LGBTQ+, and underrepresented minorities. Board governance follows best practices, with strong oversight from committees focused on science, sustainability, and risk management.

Corporate Events, Conferences, and Community Engagement

Zoetis Inc. actively participates in and hosts numerous industry events to foster knowledge exchange and showcase innovation. The company is a platinum sponsor of the American Veterinary Medical Association (AVMA) Convention, the World Veterinary Congress, and the International Pig Veterinary Society Congress. Annually, Zoetis Inc. organizes the Zoetis Global Veterinary Summit, gathering thought leaders in animal health to discuss emerging trends in genetic medicine, telemedicine, and antimicrobial stewardship. In the community, Zoetis Inc. runs the Zoetis Foundation, which supports veterinary education, disaster relief for animals, and spay/neuter programs. The company also collaborates with non-profits like the Humane Society International and Heifer International to improve animal welfare in underserved regions. During the COVID-19 pandemic, Zoetis Inc. donated vaccines and personal protective equipment to veterinary clinics and supported research on SARS-CoV-2 in animals.

Employees and Workplace Culture

Zoetis Inc. prides itself on fostering a culture of purpose, belonging, and professional growth. Employees consistently rate the company highly on engagement surveys, with 80%+ reporting that their work is meaningful and aligned with personal values. The company offers competitive compensation, comprehensive health benefits, parental leave, and a generous 401(k) match. A flexible hybrid work model is standard, and many roles offer remote options. Career development is supported through tuition reimbursement, mentorship programs, and a robust online learning platform called Zoetis Learning Academy. The company’s Parsippany campus includes a state-of-the-art wellness center, on-site childcare, and a fitness facility. Zoetis Inc. also encourages employee volunteerism by providing 16 hours of paid community service time annually. Despite a generally positive environment, some reviews on Glassdoor note occasional silos between departments and the fast pace of change, typical of a global Fortune 500 company.

Job Details & Requirements for this Posting (Detailed)

This role is a Veterinary Medical Director position within Zoetis Inc., reporting to the Vice President of Global Clinical Development. The Medical Director will provide strategic and scientific leadership for the company’s companion animal and livestock therapeutic areas. Responsibilities include overseeing clinical trial design and execution, liaising with regulatory agencies (FDA, EMA), leading cross-functional medical affairs teams, and representing Zoetis Inc. at scientific congresses. The ideal candidate holds a Doctor of Veterinary Medicine (DVM) or equivalent, with specialization in internal medicine, oncology, or pharmacology. Board certification from ACVIM or ECVIM is strongly preferred. A minimum of 10 years of experience in pharmaceutical research, veterinary practice, or academic medicine is required, with at least 5 years in a leadership capacity. The role demands excellent communication skills, an understanding of global regulatory frameworks, and a passion for innovation. Zoetis Inc. offers a competitive salary of $180,000 – $240,000, plus annual bonus, stock options, and relocation support. The position is based at the Parsippany headquarters, with up to 30% international travel. Why join Zoetis Inc.? The company provides unparalleled resources for pet and livestock health research, a collaborative culture that values scientific debate, and the opportunity to directly impact global food security and animal welfare. Employees benefit from exposure to cutting-edge technologies and a clear path to senior leadership within a market-leading organization.

Customer Reviews and Industry Reputation (Exhaustive)

GLASSDOOR

On Glassdoor, Zoetis Inc. holds an overall rating of 4.2 out of 5 based on over 2,500 reviews. 70% of employees recommend the company to a friend. Strengths consistently cited include strong company culture, meaningful mission, and excellent benefits. Employees praise the collaborative atmosphere and the ability to work on products that directly improve animal lives. Some negative feedback highlights bureaucracy, slow decision-making, and limited promotion opportunities in certain departments. The CEO approval rating is 85%, indicating solid leadership confidence.

INDEED

Indeed reviews show a rating of 3.9 out of 5 from approximately 1,200 reviews. Common positive themes: good work-life balance, supportive managers, and high-quality products. Negative mentions include below-market salary adjustments for some roles, lack of remote flexibility in manufacturing positions, and internal competition for resources. The “Culture” rating is 3.8.

GARTNER PEER INSIGHTS

On Gartner Peer Insights, Zoetis Inc. receives a customer rating of 4.5 out of 5 specifically for its veterinary diagnostic systems and practice management software (VETSPACE). Customers note the ease of integration, reliable technical support, and accuracy of diagnostic results. The few detractors mention pricing concerns for small practices and occasional software bugs.

TRUSTPILOT

Trustpilot reviews focus on pet owner products such as Simparica Trio and Revolution. The company holds a 4.1 out of 5 with over 1,800 reviews. Pet owners appreciate efficacy, convenience, and vet recommendation. Some negative reviews cite side effects (though rare) and difficulty with return policies. Zoetis Inc. responds to many complaints within 24 hours, demonstrating commitment to customer care.

G2

G2 reviews are limited for Zoetis Inc. due to the nature of its products (not pure software). However, its cloud-based platforms like Zoetis Diagnostic Cloud receive a rating of 4.3 out of 5. Users highlight data security, interoperability with practice management systems, and user-friendly dashboards. Criticism centers on lack of advanced analytics features compared to competitors.

GOOGLE REVIEWS

Google Reviews for Zoetis Inc.’s corporate office in Parsippany rerate at 4.0 out of 5 (200+ reviews). Visitors describe the campus as modern, welcoming, and environmentally conscious. Employees appreciate the on-site amenities, but some note that the cafeteria could be improved. The company’s responsiveness to feedback is highlighted positively.

LINKEDIN REPUTATION

Zoetis Inc. has a strong LinkedIn presence with over 500,000 followers. The company’s profile showcases thought leadership articles on antibiotic stewardship, vaccine innovation, and employee stories. LinkedIn ratings from current and former employees average 4.1 out of 5. The company is consistently listed as a top employer in “Animals & Veterinary” and “Pharmaceutical” categories. Industry analysts and veterinarians often engage with Zoetis Inc.’s posts, reflecting a high level of trust and credibility.

Overall, Zoetis Inc. maintains an excellent industry reputation, backed by high ratings across multiple platforms. The minor criticisms are typical for a large multinational and do not detract from its position as the world’s leading animal health company.

Why Organizations Choose Zoetis Inc.

Organizations choose Zoetis Inc. for its unmatched combination of scientific rigor, global scale, and customer intimacy. The company’s products are backed by decades of research and regulatory approvals, ensuring safety and efficacy. Veterinary clinics and livestock operations benefit from a single-source provider for vaccines, therapeutics, diagnostics, and digital tools, streamlining procurement and training. Zoetis Inc. also offers customized service packages, including field technical support, training modules, and outbreak management consulting. For large agribusinesses, the company’s data analytics platforms help optimize herd health and reduce antimicrobial usage, aligning with consumer demand for sustainable food production. Additionally, Zoetis Inc.’s extensive distribution network ensures timely delivery globally, even in remote areas. Partnering with Zoetis Inc. also enhances an organization’s reputation by association with a trusted brand committed to ethical practices. Many long-term clients have reported reduced mortality rates, improved feed conversion, and higher profitability after adopting Zoetis Inc. health programs.

Official Contact Information

For inquiries and assistance, please reach out to Zoetis Inc. using the following contact details:

Address: 10 Sylvan Way, Parsippany, NJ 07054, USA
Contact Number: +1-973-699-7300
Support Number: +1-888-891-1882
Helpdesk Number: +1-800-632-9948
Website: www.zoetis.com

Official Social Media Presence

• LinkedIn: linkedin.com/company/zoetis
• Twitter/X: @Zoetis
• Facebook: facebook.com/Zoetis
• YouTube: Zoetis AnimHealth Channel
• Instagram: @zoetis

SEO FAQ Section

What is Zoetis Inc. known for?

Zoetis Inc. is known for being the world’s largest animal health company, specializing in vaccines, parasiticides, diagnostics, and genetic tests for companion animals and livestock. Its fame stems from breakthrough products like Simparica Trio and the Draxxin antibiotic family.

Where is Zoetis Inc. headquartered?

Zoetis Inc. is headquartered in Parsippany, New Jersey, United States. The corporate offices serve as the global hub for R&D, commercial strategy, and administrative support.

When was Zoetis Inc. founded?

Zoetis Inc. originated in 1952 as Pfizer’s animal health division and was officially spun off as an independent public company in 2013. Therefore, its founding as a separate entity dates to 2013, though its heritage spans over seventy years.

Who is the CEO of Zoetis Inc.?

Kristin Peck is the Chief Executive Officer of Zoetis Inc. She assumed the role in January 2020, bringing over 25 years of experience in the pharmaceutical and animal health industries.

How many employees does Zoetis Inc. have?

Zoetis Inc. employs approximately 13,000 people globally. The workforce includes veterinarians, scientists, regulatory experts, sales representatives, and manufacturing specialists.

What products does Zoetis Inc. offer?

Zoetis Inc. offers a comprehensive portfolio: vaccines (Vanguard, Poulvac), parasiticides (Simparica Trio, Revolution), anti-infectives (Draxxin, Convenia), diagnostics (Catalyst, VetScan), genetic tests (CLARIFIDE), and monoclonal antibodies (Librela for osteoarthritis).

Is Zoetis Inc. a Fortune 500 company?

Yes, Zoetis Inc. is consistently listed on the Fortune 500, reflecting its substantial revenue, profitability, and market capitalization. The company’s 2023 revenue of $8.1 billion secured its position in the ranking.

How does Zoetis Inc. support sustainability?

Zoetis Inc. has committed to achieving net-zero carbon emissions by 2040. It also promotes responsible antibiotic use, invests in “One Health” initiatives, and partners with organizations to reduce zoonotic diseases and improve food security.

What is the average salary at Zoetis Inc.?

Salaries vary widely by role. For veterinary medical directors, the range is $180,000–$240,000. For entry-level lab technicians, $40,000–$55,000. The company also offers bonus and equity incentives for all full-time employees.

Does Zoetis Inc. sponsor visas?
Zoetis Inc. sponsors work visas for highly specialized roles where qualified local talent is unavailable. Visa sponsorship is assessed on a case-by-case basis during the recruitment process.How can I apply for a job at Zoetis Inc.?

Interested candidates can apply through the official careers page at zoetis.com/careers. The platform lists all open positions and allows you to submit your resume and cover letter.

What makes Zoetis Inc. a good place to work?

Zoetis Inc. offers a purpose-driven culture, competitive compensation, comprehensive benefits, and opportunities for growth. Employees praise the collaborative environment and the ability to make a tangible impact on animal and human health.

Who are Zoetis Inc.’s main competitors?

Primary competitors include Merck Animal Health, Boehringer Ingelheim, Elanco Animal Health, and Virbac. These companies also serve the veterinary and livestock markets with overlapping product categories.

Does Zoetis Inc. have a remote work policy?

Zoetis Inc. supports a hybrid work model for corporate roles, with two to three days in the office per week. Field-based positions (sales, technical services) are fully remote. Manufacturing roles require on-site presence.

What are Zoetis Inc.’s core values?

Zoetis Inc.’s core values are Integrity, Innovation, Courage, Collaboration, and Excellence. These guide ethical behavior, scientific exploration, and customer service across the organization.

How does Zoetis Inc. ensure product safety?

Products undergo rigorous clinical trials and are approved by regulatory authorities like the FDA and EMA. Zoetis Inc. also has a robust pharmacovigilance system to monitor adverse events post-market.

What is the Zoetis Foundation?

The Zoetis Foundation is the philanthropic arm of Zoetis Inc., established in 2013. It focuses on supporting veterinary education, animal welfare programs, and community health initiatives worldwide.

Can Zoetis Inc. products be bought without a prescription?

Many Zoetis Inc. products require a veterinary prescription, especially prescription parasiticides and antibiotics. However, some over-the-counter items, such as certain nutritional supplements, are available without a prescription.

What is the significance of the name “Zoetis”?

Zoetis is derived from the Greek word “zoetic,” meaning “full of life.” The name reflects the company’s mission to improve the vitality of animals and the people who care for them.

How does Zoetis Inc. contribute to food safety?
Zoetis Inc. develops vaccines that prevent diseases in food animals, reducing the need for antibiotics and lowering the risk of foodborne pathogens. The diagnostics division also offers rapid tests for contaminants.

For organizations seeking to enhance their online presence and authority in the animal health and veterinary care sector, leveraging strategic digital marketing can complement the robust offerings of Zoetis Inc. Zoetis Inc. stands as a beacon of innovation, and businesses can amplify their reach through professional services such as SEO Guest Posting Services, which help secure high-quality backlinks, improve search rankings, and build credibility within the industry and beyond.